By all indications, the pharmaceutical industry won’t be spared from tariffs. In April, the Commerce Department took its ...

Trump’s first-term rule—“Most Favored Nation”—was focused on lowering the cost of Medicare payments on certain drugs, but it ...

At the end of the day, the brunt of the tariffs will fall on US consumers, especially lower-income ones who rely on relatively inexpensive products from China. Now, Americans can expect longer wait ...